Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

[edit this page]

MeSH Review:

Nocturnal Myoclonus Syndrome

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Nocturnal Myoclonus Syndrome

STUDY OBJECTIVE: There is continuing speculation about the relationship between attention-deficit/hyperactivity disorder (ADHD) and obstructive sleep apnea (OSA) or periodic limb movement disorder (PLMD)/restless legs syndrome [1].

Psychiatry related information on Nocturnal Myoclonus Syndrome

Dopaminergic agents, particularly dopamine agonists, have been used with increasing frequency in the treatment of restless legs syndrome and periodic limb movement disorder [2].

High impact information on Nocturnal Myoclonus Syndrome

STUDY OBJECTIVES: The etiology of Periodic Limb Movement Disorder (PLMD) as well as the precise role of melatonin in human physiology remains poorly understood [3].
Valproate for sleep consolidation in periodic limb movement disorder [4].
Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Report. Standards of Practice Committee of the American Academy of Sleep Medicine [5].
Comparison of cognitive-behavioral therapy and clonazepam for treating periodic limb movement disorder [6].

Chemical compound and disease context of Nocturnal Myoclonus Syndrome

Bupropion, periodic limb movement disorder, and ADHD [7].

References

Patients with attention-deficit/hyperactivity disorder without observed apneic episodes in sleep or daytime sleepiness have normal sleep on polysomnography. Sangal, R.B., Owens, J.A., Sangal, J. Sleep. (2005) [Pubmed]
Practice parameters for the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Littner, M.R., Kushida, C., Anderson, W.M., Bailey, D., Berry, R.B., Hirshkowitz, M., Kapen, S., Kramer, M., Lee-Chiong, T., Li, K.K., Loube, D.L., Morgenthaler, T., Wise, M. Sleep. (2004) [Pubmed]
Exogenous melatonin in periodic limb movement disorder: an open clinical trial and a hypothesis. Kunz, D., Bes, F. Sleep. (2001) [Pubmed]
Valproate for sleep consolidation in periodic limb movement disorder. Ehrenberg, B.L., Eisensehr, I., Corbett, K.E., Crowley, P.F., Walters, A.S. Journal of clinical psychopharmacology. (2000) [Pubmed]
Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Report. Standards of Practice Committee of the American Academy of Sleep Medicine. Chesson, A.L., Wise, M., Davila, D., Johnson, S., Littner, M., Anderson, W.M., Hartse, K., Rafecas, J. Sleep. (1999) [Pubmed]
Comparison of cognitive-behavioral therapy and clonazepam for treating periodic limb movement disorder. Edinger, J.D., Fins, A.I., Sullivan, R.J., Marsh, G.R., Dailey, D.S., Young, M. Sleep. (1996) [Pubmed]
Bupropion, periodic limb movement disorder, and ADHD. Malek-Ahmadi, P. Journal of the American Academy of Child and Adolescent Psychiatry. (1999) [Pubmed]

Contributions to this collaborative article are from individual authors of WikiGenes or mined by the WikiGenes Data Mining Engine from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenes Open Access Licence Privacy Policy Terms of Use apsburg